|
341
|
|
|
CKLF-CMTM1 readthrough |
- |
|
|
342
|
|
|
MIA-RAB4B readthrough (NMD candidate) |
RAB4B |
|
|
343
|
|
|
RAB4B-EGLN2 readthrough (NMD candidate) |
EGLN2, EIT-6, EIT6, HIF-PH1, HPH-1, HPH-3, PHD1, RERT-lncRNA |
|
|
344
|
|
|
NPHP3-ACAD11 readthrough (NMD candidate) |
NPHP3 |
Congenital torticollis, Cutis marmorata, Developmental delay, Eczema, Epileptic encephalopathy, Esotropia, Exotropia, Horizontal nystagmus, Hypoplasia of corpus callosum, Meckel syndrome, Nephronophthisis, Nystagmus, Oropharyngeal dysphagia, Plagiocephaly, Polycystic kidney disease, Posteriorly rotated ear, Renal-hepatic-pancreatic dysplasia, Situs inversus, Spasms x-linked, Spinocerebellar ataxiaView all (5 more) |
|
345
|
|
|
MSH5-SAPCD1 readthrough (NMD candidate) |
MSH5-C6orf26 |
Development disorder, Diabetes mellitus, Lung adenocarcinoma, Lung cancer, Lung carcinoma, Lupus erythematosus, Myasthenia gravis, Rheumatoid arthritis, Schizophrenia, Scleroderma, Takayasu arteritis, Ulcerative colitis |
|
346
|
|
|
MICOS10-NBL1 readthrough |
C1orf151-NBL1, DAN, DAND1, MINOS1-NBL1, NBL1 |
|
|
347
|
|
|
ATP6V1G2-DDX39B readthrough (NMD candidate) |
- |
|
|
348
|
|
|
PPT2-EGFL8 readthrough (NMD candidate) |
PPT-2, PPT2 |
|
|
349
|
|
|
RTEL1-TNFRSF6B readthrough (NMD candidate) |
- |
Ankylosing spondylitis, Asthma, Central nervous system neoplasms, Cholangitis, Colonic neoplasms, Colorectal adenoma, Colorectal cancer, Colorectal neoplasms, Crohn disease, Dermatitis, Dyskeratosis congenita, Glioblastoma, Glioma, Inflammatory bowel disease, Nasopharyngeal carcinoma, Psoriasis, Pulmonary fibrosis, Pulmonary fibrosis and/or bone marrow failure, Respiratory tract diseases, Ulcerative colitisView all (5 more) |
|
350
|
|
|
UBE2F-SCLY readthrough (NMD candidate) |
- |
|
